STORY FROM: Drugs & Medical Devices

Mylan Recalls Valsartan-Containing Drugs, Citing NDEA Contamination

WASHINGTON, D.C. — Mylan has initiated a voluntary recall of 15 lots of valsartan-containing drugs due to N-nitrosodiethylamine (NDEA) contamination, according to a Food and Drug Administration announcement.

On Nov. 20, Mylan announced the recall, which involves six lots of amlodipine and valsartan tablets (including the 5mg/160mg, 10mg/160mg, and 10mg/320mg strengths), seven lots of valsartan tablets (including 40 mg, 80 mg, 160 mg, and 320 mg strengths), and two lots of valsartan and hydrochlorothiazide tablets, 320mg/25mg strength.

The drugs are manufactured by Mylan Pharmaceuticals Inc. and Mylan Laboratories Limited, and the batches at issue were distributed in the United ...



Registered User Login

Username

Password

True